NASDAQ | ETF
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio ofU. S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than 250 million.
The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index.
Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.27% |
HCM | HUTCHMED DRC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.92% |
RAPT | RAPT Therapeutics Inc | Healthcare | Biotechnology | 1.89% |
NK | NantKwest Inc | Healthcare | Biotechnology | 1.84% |
TSVT | 2Seventy Bio Inc | Healthcare | Biotechnology | 1.81% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.79% |
EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.78% |
MRTX | Mirati Ther | Healthcare | Biotechnology | 1.78% |
IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.76% |
IPHA | Innate Pharma | Healthcare | Biotechnology | 1.74% |
CMPX_old | Compass Therapeutics Inc. | Other | Other | 1.72% |
IMCR | Immunocore Holdings Ltd | Healthcare | Biotechnology | 1.72% |
YMAB | Y mAbs Therapeutics | Healthcare | Biotechnology | 1.71% |
LYEL | Lyell Immunopharma Inc | Healthcare | Biotechnology | 1.69% |
SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.69% |
BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.69% |
ZA8 | ZYMEWORKS DL-00001 | Healthcare | Biotechnology | 1.67% |
SNDX | Syndax Pharmaceuticals Inc | Healthcare | Biotechnology | 1.66% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.66% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.65% |